Uric Acid Stimulates Fructokinase and Accelerates Fructose Metabolism in the Development of Fatty Liver
暂无分享,去创建一个
M. Lanaspa | C. Rivard | Richard J. Johnson | B. Rodriguez-Iturbe | M. Le | L. Sánchez-Lozada | G. Schreiner | Y. Sautin | T. Ishimoto | Christina Cicerchi | C. Roncal-Jimenez | A. Andrés-Hernando | G. Garcia | Nanxing Li | Brandi Hunter | Jeffrey Thomas | Carlos Roncal-Jimenez | Ana Andrés-Hernando | Gabriela E Garcia | MyPhuong T. Le | Takuji Ishimoto
[1] Jeanne M Clark,et al. Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes , 2012, Hepatology.
[2] A. Craxì,et al. Hyperuricemia is associated with histological liver damage in patients with non‐alcoholic fatty liver disease , 2011, Alimentary pharmacology & therapeutics.
[3] J. Girard,et al. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. , 2010, The Journal of clinical investigation.
[4] Lei Xu,et al. Hypouricemic therapy: A novel potential therapeutic option for nonalcoholic fatty liver disease , 2010, Hepatology.
[5] L. See,et al. Gout and risk of non-alcoholic fatty liver disease , 2010, Scandinavian journal of rheumatology.
[6] T. Berl,et al. The Expression of Aquaporin-1 in the Medulla of the Kidney Is Dependent on the Transcription Factor Associated with Hypertonicity, TonEBP , 2010, The Journal of Biological Chemistry.
[7] Youming Li,et al. High Serum Uric Acid Increases the Risk for Nonalcoholic Fatty Liver Disease: A Prospective Observational Study , 2010, PloS one.
[8] L. Vilar,et al. Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. , 2010, Arquivos brasileiros de endocrinologia e metabologia.
[9] Duk-Hee Kang,et al. Oxidative stress with an activation of the renin–angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction , 2010, Journal of hypertension.
[10] S. Benner,et al. Theodore E. Woodward award. The evolution of obesity: insights from the mid-Miocene. , 2010, Transactions of the American Clinical and Climatological Association.
[11] T. Joh,et al. Elevated serum uric acid is an independent risk factor for nonalcoholic fatty liver disease in Japanese undergoing a health checkup. , 2010, Acta gastro-enterologica Belgica.
[12] L. Tappy,et al. Metabolic effects of fructose and the worldwide increase in obesity. , 2010, Physiological reviews.
[13] Manabu T. Nakamura,et al. Replacing dietary glucose with fructose increases ChREBP activity and SREBP-1 protein in rat liver nucleus. , 2009, Biochemical and biophysical research communications.
[14] K. Lee. Relationship between uric acid and hepatic steatosis among Koreans. , 2009, Diabetes & metabolism.
[15] Satoru Kodama,et al. Association Between Serum Uric Acid and Development of Type 2 Diabetes , 2009, Diabetes Care.
[16] R. Kreis,et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. , 2009, The American journal of clinical nutrition.
[17] Wei Zhang,et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. , 2009, The Journal of clinical investigation.
[18] T. Nakagawa,et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? , 2009, Endocrine reviews.
[19] B. Rovin,et al. Uric acid and cardiovascular risk. , 2009, The New England journal of medicine.
[20] S. McCall,et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. , 2008, Journal of hepatology.
[21] Manabu T. Nakamura,et al. Dietary fructose induces a wide range of genes with distinct shift in carbohydrate and lipid metabolism in fed and fasted rat liver. , 2008, Biochimica et biophysica acta.
[22] H. Towle,et al. ChREBP•Mlx Is the Principal Mediator of Glucose-induced Gene Expression in the Liver* , 2006, Journal of Biological Chemistry.
[23] Takahiko Nakagawa,et al. A causal role for uric acid in fructose-induced metabolic syndrome. , 2006, American journal of physiology. Renal physiology.
[24] In-kyu Lee,et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. , 2005, Journal of the American Society of Nephrology : JASN.
[25] P. Havel. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. , 2005, Nutrition reviews.
[26] B. Viollet,et al. Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. , 2005, Diabetes.
[27] T. Vasankari. Metabolic effects of dietary fructose. , 2003, The American journal of clinical nutrition.
[28] T. Ogihara,et al. Serum Uric Acid and Plasma Norepinephrine Concentrations Predict Subsequent Weight Gain and Blood Pressure Elevation , 2003, Hypertension.
[29] Sookja K. Chung,et al. Contribution of polyol pathway to diabetes-induced oxidative stress. , 2003, Journal of the American Society of Nephrology : JASN.
[30] K. Tuttle,et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? , 2003, Hypertension.
[31] Ping Li,et al. Uric Acid Stimulates Monocyte Chemoattractant Protein‐1 Production in Vascular Smooth Muscle Cells Via Mitogen‐Activated Protein Kinase and Cyclooxygenase‐2 , 2003, Hypertension.
[32] H. Yamashita,et al. Mechanism for Fatty Acid “Sparing” Effect on Glucose-induced Transcription , 2002, The Journal of Biological Chemistry.
[33] S. Yusuf,et al. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.
[34] H. Cortez‐Pinto,et al. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. , 1999, JAMA.
[35] C. Burant,et al. Rapid reversible substrate regulation of fructose transporter expression in rat small intestine and kidney. , 1994, The American journal of physiology.
[36] G. Reaven,et al. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. , 1991, JAMA.
[37] G. Crouzoulon,et al. Dietary regulation of fructose metabolism in the intestine and in the liver of the rat. Duration of the effects of a high fructose diet after the return to the standard diet. , 1991, Archives internationales de physiologie, de biochimie et de biophysique.
[38] I. Wanless,et al. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors , 1990, Hepatology.
[39] G. Vandenberghe. Fructose: metabolism and short-term effects on carbohydrate and purine metabolic pathways. , 1986 .
[40] O. E. Michaelis,et al. Plasma fructose, uric acid, and inorganic phosphorus responses of hyperinsulinemic men fed fructose. , 1986, Journal of the American College of Nutrition.
[41] G. van den Berghe. Fructose: metabolism and short-term effects on carbohydrate and purine metabolic pathways. , 1986, Progress in biochemical pharmacology.
[42] O. E. Michaelis,et al. Effects of dietary fructose on plasma glucose and hormone responses in normal and hyperinsulinemic men. , 1983, The Journal of nutrition.
[43] J. Hallfrisch,et al. Blood lipid distribution of hyperinsulinemic men consuming three levels of fructose. , 1983, The American journal of clinical nutrition.
[44] O. Zelder,et al. Depletion of Liver Adenosine Phosphates and Metabolic Effects of Intravenous Infusion of Fructose or Sorbitol in Man and in the Rat *, ** , 1973, European journal of clinical investigation.